PE-backed StageBio and Tox Path Specialists merge

StageBio, which is backed by Ampersand Capital Partners, has merged with Tox Path Specialists. No financial terms were disclosed. Based in Mount Jackson, Virginia, StageBio is a provider of GLP-compliant research and preclinical histology, pathology and specimen archiving services for the biopharmaceutical, medical device and contract research industries. And, Frederick, Maryland-based Tox Path is a neuropathology lab

DealsNorth AmericaUSHealthcareBriefs